IP Library Granted Patent US 7,819,908
Granted Patent B2
US 7,819,908 · App. 11/016,548 · Granted Oct 26, 2010

Compositions and methods for reducing lung volume

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,819,908
App. No.
11/016,548
Granted
Oct 26, 2010
Kind
B2
Abstract

The invention includes a method for performing non-surgical lung volume reduction in a patient by applying an amount of energy with a catheter to a diseased alveolar region of the lung of a patient having emphysema, wherein the amount of energy is sufficient to damage the epithelial cells and the epithelial barrier within the diseased alveolar region of the lung and collapse at least a portion of said region thereby reducing the lung volume, and wherein the energy comprises thermal energy, electrical energy, and ultrasonic energy.

Claims (7)

1. A method for non-surgical lung volume reduction, the method comprising applying an amount of energy with a catheter to a diseased alveolar region of the lung of a patient having emphysema, wherein the amount of energy is sufficient to damage the epithelial cells and the epithelial barrier within the diseased alveolar region of the lung and collapse at least a portion of said region thereby reducing the lung volume.

2. The method of claim 1 , wherein the energy comprises thermal energy and is applied as heat.

3. The method of claim 2 , wherein the catheter transfers heat to the alveolar region.

4. The method of claim 1 , wherein the energy comprises ultrasonic energy.

5. The method of claim 4 , wherein the catheter transmits the ultrasonic energy to the alveolar region.

6. The method of claim 1 , wherein the energy comprises electrical energy.

7. The method of claim 6 , wherein the catheter transmits the electrical energy to the alveolar region.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Mar 5, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 073980/0673 →
SECURITY INTEREST Recorded Nov 30, 2022
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 061929/0750 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
RELEASE OF SECURITY INTEREST Recorded May 26, 2015
From: ROSSE ENTERPRISES, LTD.
To: AERIS THERAPEUTICS, LLC.
Reel/Frame 035714/0886 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2015
From: AERIS THERAPEUTICS, LLC.
To: PULMONX CORPORATION
Reel/Frame 035715/0265 →
SECURITY AGREEMENT Recorded Feb 9, 2012
From: AERIS THERAPEUTICS, LLC
To: ROSSE ENTERPRISES, LTD.
Reel/Frame 027683/0003 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2011
From: AERIS THERAPEUTICS, INC.
To: AERIS THERAPEUTICS, LLC
Reel/Frame 026170/0254 →